According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -$0.02 B. In 2020 the company made an earning of $3.14 M an increase over its 2019 earnings that were of -$0.02 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2021 (TTM) | -$0.02 B | -732.31% |
2020 | $3.14 M | -130.53% |
2019 | -$0.02 B | -45.08% |
2018 | -$0.02 B | -75.15% |
2017 | -$0.08 B | 308.12% |
2016 | -$0.02 B | -21.31% |
2015 | -$0.03 B | -5.37% |
2014 | -$0.03 B | -8.33% |
2013 | -$0.03 B | 139.6% |
2012 | -$0.02 B | -63.67% |
2011 | -$0.04 B | -20.48% |
2010 | -$0.04 B | 22.52% |
2009 | -$0.04 B | 32.26% |
2008 | -$0.03 B | -17.64% |
2007 | -$0.03 B | 200.36% |
2006 | -$9.78 M | 10373.34% |
2005 | -$0.1 M | -43.66% |
2004 | -$0.17 M | 12.35% |
2003 | -$0.15 M | -11.1% |
2002 | -$0.17 M | -57.03% |
2001 | -$0.39 M |